FDA Issues Alert on Biogen's (BIIB) Tysabri: Continued Use Increases Risk of Developing PML
Tweet Send to a Friend
In just the last few minutes of trading, shares of Biogen (Nasdaq: BIIB) are swinging wildly as the FDA has ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
